This article is more than 5 years old. Information may no longer be current.
University of Southampton receives funding for ID research investment analysis
Click Here to Manage Email Alerts
Researchers from the University of Southampton will investigate the impact of grants and research investments on the global burden of several infectious diseases, according to a press release.
Supported by more than $570,000 from the Bill and Melinda Gates Foundation, the Research Investments in Global Health study will map research funding to institutions in the G20 countries and compare that with spending and disease impact in affected areas. In addition, researchers will highlight each country’s investment relative to disease burden, and highlight global and national gaps in infectious disease research.
“The high disease burden, particularly among young and elderly populations in poor to middle income countries, could potentially be addressed by further investment in research,” Stuart C. Clarke, PhD, of the University of Southampton, said in the press release. “We will quantify the contribution of research funds that these infections receive compared to research involving other pathogens that are important in human health. This will give policymakers a comprehensive picture of where there’s been a lack of funding relative to the impact of the disease and help to set global research investment priorities.”
According to the release, the study will focus on research pertaining to pneumonia, maternal and neonatal infections. Set to begin in October, the findings will be compiled in an open-access database so that potential funders and policymakers can easily consider the data.